
Prognostic but not predictive: the clinical implications of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy
<a href="https://news.google.com/rss/articles/CBMikAJBVV95cUxQOVVPRWJKaDFjdUF6LWNDYzhubHJ5aVgzOW5mRUdQSTY1S0JGemZhMzhrMXVreVZUSjRhYkF2TjZBYldXNWhFamw5Y3cyQ3ZlcGg0RjNvcHlPRkxHZ3J4WG9NcHZxdkUyZlY1cVdCa0dHYUkwNTFRNWExTElRd3E4Z1hxVTBKOUxHS1VBc3M3UHFoN0taN0pLdUU5d2hldG94NjhCQ1FkTS1rbG8yclBKTzdObHkzdUp2ZjdqQ0VyZEZUNmhjSmxONnZGRnBOY1NSLWtqX19yVVk0T0o4UWpCbVAxb3YtdmpoVWdpLWlVLW5Dc1lwY1E2WFFLN1dTU1daSG5oajE3R01qRU5Cc0NrNA?oc=5" target="_blank">Prognostic but not predictive: the clinical implications of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncology Central</font>
